1.80
price up icon0.84%   0.02
 
loading

Precigen Inc Azioni (PGEN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Income/Loss From Continuing Operations Before Tax
28.82%
-23.77
-33.39 -19.80 -20.38 -22.79
Income Tax Expense/Benefit, Deferred
91.78%
-0.029
-0.353 -0.013 -0.058 -0.055
Income Tax Expense/Benefit
91.27%
-0.029
-0.332 -0.006 -0.065 -0.055
Income/Loss From Continuing Operations After Tax
28.19%
-23.74
-33.06 -19.80 -20.32 -22.73
Net Income/Loss
28.19%
-23.74
-33.06 -19.80 -20.32 -22.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16,959%
249.22
1.461 248.52 248.00 229.77
Diluted Average Shares
16,959%
249.22
1.461 248.52 248.00 229.77
Basic Earnings Per Share
23.08%
-0.10
-0.13 -0.08 -0.08 -0.10
Diluted Earnings Per Share
23.08%
-0.10
-0.13 -0.08 -0.08 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$79.06
price up icon 0.79%
$36.94
price down icon 1.81%
$113.30
price up icon 3.28%
$28.85
price up icon 0.73%
$110.28
price down icon 1.42%
biotechnology ONC
$289.00
price up icon 0.25%
Capitalizzazione:     |  Volume (24 ore):